Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,607 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,607 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,607 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,607 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,607 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,607 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,607 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Dec 2025
Christopher Gibson Chief Executive Officer
Sold on a plan
$185.20K 40,000 at 4.63
4.1%
Planned (10b5-1)
4 Dec 2025
Harlan S Robins Chief Scientific Officer
Sold on a plan
$166.10K 10,000 at 16.61
0.8%
Planned (10b5-1)
4 Dec 2025
Andy Dignan President
Sold on a plan 2×
$152.33K 7,512 at 20.28
3.5%
Planned (10b5-1)
4 Dec 2025
Bruce K Posey Chief Legal Officer
Sold on a plan
$150.00K 1,000 at 150.00
1.4%
Planned (10b5-1)
4 Dec 2025
Lawson E Whiting President & CEO
Sold on a plan
$148.34K 4,785 at 31.00
100.0%
Sold half or more
4 Dec 2025
Jack Bendheim President and CEO · indirect
Sold on a plan 2×
$145.10K 3,520 at 41.22
6.6%
Planned (10b5-1)
4 Dec 2025
Claire McDonough Chief Financial Officer
Sold on a plan
$144.70K 8,039 at 18.00
1.1%
Planned (10b5-1)
4 Dec 2025
Nancy Lurker Director
Sold on a plan
$140.48K 9,300 at 15.11
4.3%
Planned (10b5-1)
4 Dec 2025
Lori C. Locke Chief Accounting Officer
Sold on a plan
$120.70K 5,000 at 24.14
4.0%
Planned (10b5-1)
4 Dec 2025
Paul L Alpern VP and General Counsel
Sold on a plan
$120.64K 7,500 at 16.09
10.3%
Planned (10b5-1)
4 Dec 2025
James Ronald Dail Chief Operating Officer
Sold on a plan
$112.61K 662 at 170.11
2.1%
Planned (10b5-1)
4 Dec 2025
Jane Henderson Chief Financial Officer
Sold on a plan
$112.50K 1,500 at 75.00
0.8%
Planned (10b5-1)
4 Dec 2025
Stephen W. Hope Chief Accounting Officer
Sold on a plan
$107.03K 4,800 at 22.30
1.5%
Planned (10b5-1)
4 Dec 2025
Justyn Russell Howard Executive Chair
Sold on a plan
$105.05K 10,291 at 10.21
3.5%
Planned (10b5-1)
4 Dec 2025
Daryl E Raiford Chief Financial Officer
Sold on a plan 2×
$97.41K 6,719 at 14.50
6.8%
Planned (10b5-1)
4 Dec 2025
Ansbert Gadicke Former 10% Owner · indirect also filed by MPM BioVentures 2014, L.P.
Sold on a plan
$80.73K 83,230 at 0.97
1.7%
Planned (10b5-1)
4 Dec 2025
Jack R Lazar Director
Sold on a plan
$79.42K 2,500 at 31.77
9.0%
Planned (10b5-1)
4 Dec 2025
Annie McGuire SVP, General Counsel
Sold on a plan 2×
$67.26K 1,422 at 47.30
1.8%
Planned (10b5-1)
4 Dec 2025
Mark Hopman Chief Commercial Officer
Sold on a plan
$63.19K 2,061 at 30.66
1.5%
Planned (10b5-1)
4 Dec 2025
John Leite Chief Commercial Officer-CLIA
Sold on a plan
$60.72K 1,278 at 47.51
1.5%
Planned (10b5-1)
4 Dec 2025
Leena Mansharamani SVP, Chief Accounting Officer
Sold on a plan 3×
$60.23K 2,951 at 20.41
7.1%
Planned (10b5-1)
4 Dec 2025
Derek J Maetzold Pres. & Chief Exec. Officer
Sold on a plan
$53.60K 1,339 at 40.03
3.4%
Planned (10b5-1)
4 Dec 2025
Barry Ticho Chief Medical Officer
Sold on a plan 2×
$52.35K 1,696 at 30.87
6.7%
Planned (10b5-1)
4 Dec 2025
Luke Evnin Director · indirect
Sold on a plan
$51.81K 53,416 at 0.97
1.7%
Planned (10b5-1)
4 Dec 2025
Matthew Rizik Director
Sold on a plan
$49.64K 2,500 at 19.86
0.3%
Planned (10b5-1)
4 Dec 2025
Liberman A Jeffery President and COO · indirect
Sold on a plan
$40.02K 14,291 at 2.80
4.7%
Planned (10b5-1)
4 Dec 2025
Keelan Adamson President and CEO
Sold on a plan
$38.11K 8,469 at 4.50
0.6%
Planned (10b5-1)
4 Dec 2025
Jonathan Allan General Counsel & Corp Sec
Sold on a plan 2×
$31.42K 1,018 at 30.87
4.0%
Planned (10b5-1)
4 Dec 2025
Andrew Bialecki Chief Executive Officer
Sold on a plan
$28.56K 952 at 30.00
100%
Sold half or more
4 Dec 2025
Merline Saintil Director
Sold on a plan
$25.77K 168 at 153.38
2.3%
Planned (10b5-1)
4 Dec 2025
Dan Paterson President and CEO
Sold on a plan
$20.00K 2,000 at 10.00
0.5%
Planned (10b5-1)
4 Dec 2025
Allison Swartz EVP, GC
Sold on a plan
$13.03K 530 at 24.59
0.7%
Planned (10b5-1)
4 Dec 2025
Reuven Spiegel Executive Vice President, DKL
Sold on a plan
$11.47K 250 at 45.86
1.0%
Planned (10b5-1)
4 Dec 2025
Andrew Cappotelli Sr Vice President Operations
Sold on a plan
$10.14K 69 at 146.90
0.3%
Planned (10b5-1)
3 Dec 2025
Jeffrey M Leiden Executive Chairman
Sold on a plan 12×
$28.65M 63,781 at 449.20
72.6%
Sold half or more
3 Dec 2025
Scott D Cook Director · indirect
Sold on a plan 30×
$28.16M 43,868 at 641.98
0.7%
Planned (10b5-1)
3 Dec 2025
Lee Klarich EVP Chief Product & Tech Ofcr
Sold on a plan 7×
$23.18M 120,774 at 191.91
26.9%
Planned (10b5-1)
3 Dec 2025
Daniel Martin Gallagher Jr Chief Legal Officer
Sold on a plan 10×
$15.86M 120,000 at 132.13
21.8%
Planned (10b5-1)
3 Dec 2025
J Scott Kirby Chief Executive Officer
Sold on a plan
$12.94M 120,000 at 107.87
15.3%
Planned (10b5-1)
3 Dec 2025
Sold on a plan 2×
$12.38M 30,928 at 400.34
17.7%
Planned (10b5-1)
3 Dec 2025
Matthew Prince CEO & Board Co-Chair · indirect
Sold on a plan 7×
$10.59M 52,384 at 202.19
100%
Sold half or more
3 Dec 2025
Sundar Pichai Chief Executive Officer
Sold on a plan 8×
$10.38M 32,500 at 319.50
1.4%
Planned (10b5-1)
3 Dec 2025
Thomas Taira President, Special Projects
Sold on a plan
$10.00M 25,000 at 400.00
23.6%
Planned (10b5-1)
3 Dec 2025
Steven M. Quirk Chief Brokerage Officer
Sold on a plan 10×
$6.55M 49,942 at 131.15
47.8%
Planned (10b5-1)
3 Dec 2025
Kris Rasmussen Chief Technology Officer
Sold on a plan 3×
$6.51M 177,387 at 36.71
1.6%
Planned (10b5-1)
3 Dec 2025
Charles F Wagner Jr EVP, Co & Fo
Sold on a plan 2×
$6.38M 14,000 at 456.00
27.1%
Planned (10b5-1)
3 Dec 2025
Olivier Pomel Chief Executive Officer
Sold on a plan 4×
$5.09M 32,923 at 154.63
6.0%
Planned (10b5-1)
3 Dec 2025
Nathan Blecharczyk Chief Strategy Officer
Sold on a plan
$4.79M 39,806 at 120.22
23.3%
Planned (10b5-1)
3 Dec 2025
George W. Lloyd EVP, Investments & CLO · indirect
Sold on a plan
$4.38M 110,000 at 39.77
50.0%
Sold half or more
Showing 21,801–21,850 of 23,607. ← Newer Page 437 of 473 Older →